Major global pharmaceutical firm Boehringer plans to create a blockchain-powered care network for patients with diabetes.
А leading pharmaceutical firm Boehringer Ingelheim has teamed up with blockchain-based healthcare platform Solve.Care, according to a press release shared with Cointelegraph on June 6.
Germany-based Boehringer, one of the world’s 20 largest pharma companies, and Solve.Care are planning to build a blockchain and digital asset-powered network for trusted sharing of data about patients with diabetes.
Based on Solve.Care’s blockchain platform, the new healthcare system is known as the Diabetes Care Administration Network. The network intends to provide assistance in coordinating care for patients, as well as to share information about the risks associated with diabetes, prevention and symptoms, among others.
The network will purportedly implement Solve.Care’s care coordination tool dubbed Care.Wallets in order to support patients with the disease.
The care network is expected to go live on or before year-end 2019, the press release notes, adding that the system will be initially rolled out for over 25,000 patients across major American accountable care firm, Arizona Care Network (ACN).
Recently, global retail giant Walmart was reported to join blockchain-enabled pharmaceutical consortium MediLedger, following four major Amercian firms in the industry, including Pfizer.
Previously, Cointelegraph reported that the Association of amyotrophic lateral sclerosis (ALS) partnered with a major cryptocurrency project, the Tron Foundation, to launch a blockchain-enabled charity campaign to raise awareness about ALS and raise donations for research into treatment for the disease.
